MWNA
AGN

Marshall Wace North America’s Allergan plc AGN Stock Holding History

Marshall Wace North America’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-228,564
Closed -$43.7M – 1758
2019
Q4 		$43.7M Buy
228,564
+133,457
+140% +$24.1M 0.21% 132
2019
Q3 		$16M Sell
95,107
-93,697
-50% -$15.3M 0.09% 196
2019
Q2 		$31.6M Buy
188,804
+185,716
+6,014% +$25.7M 0.2% 118
2019
Q1 		$452K Buy
+3,088
New +$448K ﹤0.01% 830
2018
Q4 		– Sell
-291,146
Closed -$55.5M – 1728
2018
Q3 		$55.5M Buy
291,146
+179,280
+160% +$32.9M 0.38% 67
2018
Q2 		$18.7M Buy
111,866
+82,481
+281% +$13.2M 0.11% 219
2018
Q1 		$4.95M Sell
29,385
-292,126
-91% -$49M 0.02% 574
2017
Q4 		$52.6M Buy
321,511
+290,250
+928% +$52.1M 0.29% 79
2017
Q3 		$6.41M Buy
31,261
+3,182
+11% +$740K 0.04% 479
2017
Q2 		$6.82M Buy
+28,079
New +$6.6M 0.05% 405
2013
Q4 		$924K Sell
5,498
-7,716
-58% -$1.21M 0.02% 420
2013
Q3 		$1.9M Buy
13,214
+2,930
+28% +$390K 0.06% 274
2013
Q2 		$1.3M Buy
+10,284
New +$1.16M 0.1% 204

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace North America's AGN Position: Q1 2020 in Review

Marshall Wace North America sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 228,564 shares — an estimated $43.7M sold.

Marshall Wace North America first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $55.5M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Marshall Wace North America reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace North America sold 228,564 Allergan plc shares in Q1 2020, an estimated $43.7M.
  • Marshall Wace North America first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Marshall Wace North America's Allergan plc position peaked at $55.5M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.